Riluzole (Rilutek), a drug used in treatment of patients with amyotrophic lateral sclerosis, did not help prevent brain matter loss in early relapsing/remitting multiple sclerosis, researchers reported here.
After adjustment for key differences in the randomization process, Emmanuelle Waubant, MD, assistant professor of neurology at the University of California San Francisco, said that treatment with riluzole resulted in a decrease in brain volume by 0.26% a year compared with placebo treatment (difference of -0.26, 95% CI -0.057 to 0.014, P=0.22)...... Read More - http://www.ms-uk.org/MSnews
ALS drug fails as treatment for early MS
ALS drug fails as treatment for early MS
MS-UK - http://www.ms-uk.org/
-
CureOrBust
- Family Elder
- Posts: 3374
- Joined: Wed Jul 27, 2005 2:00 pm
- Location: Sydney, Australia
Re: ALS drug fails as treatment for early MS
If the drug works for ALS, I would of expected better results with SPMS rather than RRMS. Why did they try it on RRMS and CIS?